BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14688422)

  • 1. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro.
    Wollensak G; Spörl E; Reber F; Pillunat L; Funk R
    Ophthalmic Res; 2003; 35(6):324-8. PubMed ID: 14688422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
    Wollensak G; Spoerl E; Reber F; Seiler T
    Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit.
    Wollensak G; Spoerl E; Wilsch M; Seiler T
    J Cataract Refract Surg; 2003 Sep; 29(9):1786-90. PubMed ID: 14522302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of UVA Cytotoxicity for Human Endothelium in an Ex Vivo Corneal Cross-linking Experimental Setting.
    Mooren P; Gobin L; Bostan N; Wouters K; Zakaria N; Mathysen DG; Koppen C
    J Refract Surg; 2016 Jan; 32(1):41-6. PubMed ID: 26812713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.
    Wollensak G; Spoerl E; Wilsch M; Seiler T
    Cornea; 2004 Jan; 23(1):43-9. PubMed ID: 14701957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of UVA-riboflavin cross-linking of the cornea.
    Spoerl E; Mrochen M; Sliney D; Trokel S; Seiler T
    Cornea; 2007 May; 26(4):385-9. PubMed ID: 17457183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermomechanical behavior of collagen-cross-linked porcine cornea.
    Spoerl E; Wollensak G; Dittert DD; Seiler T
    Ophthalmologica; 2004; 218(2):136-40. PubMed ID: 15004504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased resistance of crosslinked cornea against enzymatic digestion.
    Spoerl E; Wollensak G; Seiler T
    Curr Eye Res; 2004 Jul; 29(1):35-40. PubMed ID: 15370365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal collagen crosslinking in vitro: inhibited regeneration of human limbal epithelial cells after riboflavin-ultraviolet-A exposure.
    Thorsrud A; Nicolaissen B; Drolsum L
    J Cataract Refract Surg; 2012 Jun; 38(6):1072-6. PubMed ID: 22624908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure.
    Krueger RR; Herekar S; Spoerl E
    Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas].
    Schilde T; Kohlhaas M; Spoerl E; Pillunat LE
    Ophthalmologe; 2008 Feb; 105(2):165-9. PubMed ID: 17955247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Toxicity/Fixation Balance for Corneal Cross-Linking With Sodium Hydroxymethylglycinate (SMG) and Riboflavin-UVA (CXL) in an Ex Vivo Rabbit Model Using Confocal Laser Scanning Fluorescence Microscopy.
    Kim SY; Babar N; Munteanu EL; Takaoka A; Zyablitskaya M; Nagasaki T; Trokel SL; Paik DC
    Cornea; 2016 Apr; 35(4):550-6. PubMed ID: 26807905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient corneal endothelial changes following accelerated collagen cross-linking for the treatment of progressive keratoconus.
    Cingü AK; Sogutlu-Sari E; Cınar Y; Sahin M; Türkçü FM; Yüksel H; Sahin A; Caça I
    Cutan Ocul Toxicol; 2014 Jun; 33(2):127-31. PubMed ID: 23859485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term biomechanical properties of rabbit cornea after photodynamic collagen crosslinking.
    Wollensak G; Iomdina E
    Acta Ophthalmol; 2009 Feb; 87(1):48-51. PubMed ID: 18547280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.
    Zhu Y; Reinach PS; Zhu H; Tan Q; Zheng Q; Qu J; Chen W
    PLoS One; 2017; 12(6):e0179580. PubMed ID: 28644862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light.
    Kohlhaas M; Spoerl E; Schilde T; Unger G; Wittig C; Pillunat LE
    J Cataract Refract Surg; 2006 Feb; 32(2):279-83. PubMed ID: 16565005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA.
    Wollensak G; Iomdina E; Dittert DD; Herbst H
    Cornea; 2007 Jun; 26(5):600-5. PubMed ID: 17525659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of various compositions of riboflavin eye drops on the intraoperative corneal thickness during UVA-cross-linking in keratoconus eyes].
    Vetter JM; Tubic-Grozdanis M; Faust M; Lorenz K; Gericke A; Stoffelns BM
    Klin Monbl Augenheilkd; 2011 Jun; 228(6):509-14. PubMed ID: 21656433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.
    Caporossi A; Baiocchi S; Mazzotta C; Traversi C; Caporossi T
    J Cataract Refract Surg; 2006 May; 32(5):837-45. PubMed ID: 16765803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative pachymetric measurements during corneal collagen cross-linking with riboflavin and ultraviolet A irradiation.
    Kymionis GD; Kounis GA; Portaliou DM; Grentzelos MA; Karavitaki AE; Coskunseven E; Jankov MR; Pallikaris IG
    Ophthalmology; 2009 Dec; 116(12):2336-9. PubMed ID: 19850346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.